• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征非肥胖儿童中瘦素、脂联素及其他代谢参数的浓度

Concentrations of leptin, adiponectin and other metabolic parameters in non-obese children with Down syndrome.

作者信息

Tenneti Nikhil, Dayal Devi, Sharda Sheetal, Panigrahi Inusha, Didi Mohammed, Attri Savita Verma, Sachdeva Naresh, Bhalla Anil Kumar

机构信息

.

出版信息

J Pediatr Endocrinol Metab. 2017 Aug 28;30(8):831-837. doi: 10.1515/jpem-2016-0422.

DOI:10.1515/jpem-2016-0422
PMID:28749784
Abstract

BACKGROUND

Recent data indicates that adults with Down syndrome (DS) are at increased risk for cardiovascular disease (CVD) that significantly contributes to their morbidity and mortality. Although identification of cardiometabolic risk factors during childhood is desirable to design preventive interventions, the data on such risk factors in children with DS is scarce. The aim of this study was to study the cardiometabolic risk factors such as insulin resistance (IR), leptin and adiponectin concentrations, lipid abnormalities and leptin resistance in non-obese children with DS.

METHODS

This cross-sectional case control study included karyotype confirmed trisomy-21 DS children aged 2-12 years and their matched healthy controls. After detailed anthropometry, weight, height and body mass index (BMI) standard deviation scores (SDSs) were calculated with reference data. Laboratory evaluation included determination of fasting lipid parameters, insulin, glucose, leptin and adiponectin concentrations. The homeostasis model assessment method (HOMA-IR) was used to assess IR and the ratio of leptin to BMI was used as an index of leptin resistance.

RESULTS

Seventy-seven children (39 with DS and 38 controls) comprised the study cohort. The anthropometric parameters were similar in the two groups. Children with DS showed significantly higher mean leptin concentrations (2.098±1.68 ng/mL vs. 1.44±0.52 ng/mL, p-value: 0.00) and higher indices of leptin resistance (0.127±0.085 vs. 0.09±0.03, p-value: 0.001) as compared to controls. Fasting adiponectin concentrations were lower (20.64±19.87 ng/mL vs. 32.58±34.25 ng/mL, p-value: 0.21) and fasting glucose higher (89.25±8.12 mg/dL vs. 85.71±5.52 mg/dL, p-value: 0.06) in the DS group as compared to the controls but the differences did not reach statistical significance. The concentrations of insulin, various lipid parameters and calculated HOMA-IR values were similar in the two groups. In the DS group, five children were identified to have high (>75th centile) leptin levels and four as impaired fasting glucose as compared to none in the controls.

CONCLUSIONS

Alterations of several cardiometabolic risk factors, in particular, leptin concentrations and leptin resistance are present in children with DS. The presence of hyperleptinemia without hyperinsulinemia suggests a probable inherent genetic basis for increased leptin resistance in patients with DS. There is a need for larger studies to further understand increased leptin resistance in DS that may contribute to increased CVD related morbidity and mortality in these patients.

摘要

背景

近期数据表明,患有唐氏综合征(DS)的成年人患心血管疾病(CVD)的风险增加,这对其发病率和死亡率有显著影响。尽管在儿童期识别心脏代谢危险因素对于设计预防干预措施是可取的,但关于DS患儿此类危险因素的数据却很匮乏。本研究的目的是研究非肥胖DS患儿的心脏代谢危险因素,如胰岛素抵抗(IR)、瘦素和脂联素浓度、血脂异常及瘦素抵抗。

方法

这项横断面病例对照研究纳入了经核型确认的2至12岁的21三体DS患儿及其匹配的健康对照。在进行详细的人体测量后,根据参考数据计算体重、身高和体重指数(BMI)标准差评分(SDS)。实验室评估包括测定空腹血脂参数、胰岛素、葡萄糖、瘦素和脂联素浓度。采用稳态模型评估法(HOMA-IR)评估IR,瘦素与BMI的比值用作瘦素抵抗指数。

结果

77名儿童(39名DS患儿和38名对照)组成了研究队列。两组的人体测量参数相似。与对照组相比,DS患儿的平均瘦素浓度显著更高(2.098±1.68 ng/mL对1.44±0.52 ng/mL,p值:0.00),瘦素抵抗指数也更高(0.127±0.085对0.09±0.03,p值:0.001)。与对照组相比(p值:0.21),DS组的空腹脂联素浓度较低(20.64±19. ... ng/mL对32.58±34.25 ng/mL),空腹血糖较高(89.25±8.12 mg/dL对85.71±5.52 mg/dL,p值:0.06),但差异未达到统计学意义。两组的胰岛素浓度、各种血脂参数及计算得出的HOMA-IR值相似。在DS组中,有5名儿童被确定瘦素水平高(>第75百分位数),4名儿童空腹血糖受损,而对照组中无此情况。

结论

DS患儿存在多种心脏代谢危险因素的改变,尤其是瘦素浓度和瘦素抵抗。高瘦素血症而无高胰岛素血症的存在提示DS患者瘦素抵抗增加可能有潜在的遗传基础。需要进行更大规模的研究以进一步了解DS患者中瘦素抵抗增加的情况,这可能导致这些患者心血管疾病相关发病率和死亡率的增加。

相似文献

1
Concentrations of leptin, adiponectin and other metabolic parameters in non-obese children with Down syndrome.唐氏综合征非肥胖儿童中瘦素、脂联素及其他代谢参数的浓度
J Pediatr Endocrinol Metab. 2017 Aug 28;30(8):831-837. doi: 10.1515/jpem-2016-0422.
2
Serum leptin, adiponectin, and resistin among adult patients with acanthosis nigricans: correlations with insulin resistance and risk factors for cardiovascular disease.成年黑棘皮病患者的血清瘦素、脂联素和抵抗素:与胰岛素抵抗及心血管疾病危险因素的相关性
Int J Dermatol. 2014 Oct;53(10):e410-20. doi: 10.1111/ijd.12340. Epub 2013 Oct 29.
3
Serum adiponectin, body adiposity and metabolic parameters in obese Egyptian children with Down syndrome.肥胖唐氏综合征埃及儿童血清脂联素、体脂分布和代谢参数。
J Pediatr Endocrinol Metab. 2021 Aug 5;34(11):1401-1410. doi: 10.1515/jpem-2021-0324. Print 2021 Nov 25.
4
Serum adiponectin and leptin levels and insulin resistance in children born large for gestational age are affected by the degree of overweight.大于胎龄儿血清脂联素、瘦素水平及胰岛素抵抗受超重程度影响。
Clin Endocrinol (Oxf). 2007 Mar;66(3):353-9. doi: 10.1111/j.1365-2265.2006.02736.x.
5
Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.肥胖儿童和青少年中的内脂素及其与胰岛素抵抗和代谢综合征的关联。
Scand J Clin Lab Invest. 2015 Apr;75(2):183-8. doi: 10.3109/00365513.2014.1003594. Epub 2015 Feb 27.
6
Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women.抑郁女性的瘦素、脂联素、瘦素与脂联素比值及胰岛素抵抗
Neuro Endocrinol Lett. 2009;30(3):387-95.
7
The Homeostasis Model Assessment-adiponectin (HOMA-AD) is the most sensitive predictor of insulin resistance in obese children.稳态模型评估-脂联素(HOMA-AD)是肥胖儿童胰岛素抵抗的最敏感预测指标。
Ann Endocrinol (Paris). 2012 Feb;73(1):26-33. doi: 10.1016/j.ando.2011.12.002. Epub 2012 Jan 20.
8
The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome.儿童及青少年肥胖症患者血清脂联素、肿瘤坏死因子-α、瘦素水平与胰岛素敏感性之间的关系:脂联素是代谢综合征的一个标志物。
J Clin Res Pediatr Endocrinol. 2009;1(5):233-9. doi: 10.4274/jcrpe.v1i5.233. Epub 2009 Aug 4.
9
Insulin Resistance in Nondiabetic Peritoneal Dialysis Patients: Associations with Body Composition, Peritoneal Transport, and Peritoneal Glucose Absorption.非糖尿病腹膜透析患者的胰岛素抵抗:与身体组成、腹膜转运及腹膜葡萄糖吸收的关系
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2205-12. doi: 10.2215/CJN.03170315. Epub 2015 Oct 27.
10
The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.多成分疗法在肥胖青少年代谢综合征、炎症及心血管风险中的作用
Br J Nutr. 2015 Jun 28;113(12):1920-30. doi: 10.1017/S0007114515001129. Epub 2015 Apr 24.

引用本文的文献

1
Leptin levels are associated with body mass index and Alzheimer's disease in Down syndrome.瘦素水平与唐氏综合征患者的体重指数及阿尔茨海默病相关。
Alzheimers Dement. 2025 Jul;21(7):e70448. doi: 10.1002/alz.70448.
2
Parental perception of facilitators and barriers to health among young children with down syndrome: a qualitative study.唐氏综合征幼儿父母对促进健康因素及障碍的认知:一项定性研究
Front Pediatr. 2023 Jul 11;11:1155850. doi: 10.3389/fped.2023.1155850. eCollection 2023.
3
Profiling of circulating chromosome 21-encoded microRNAs, miR-155, and let-7c, in down syndrome.
唐氏综合征中循环染色体 21 编码 microRNAs,miR-155 和 let-7c 的分析。
Mol Genet Genomic Med. 2022 Jun;10(6):e1938. doi: 10.1002/mgg3.1938. Epub 2022 Apr 12.
4
Adiponectin Modulation by Genotype and Maternal Choline Supplementation in a Mouse Model of Down Syndrome and Alzheimer's Disease.唐氏综合征和阿尔茨海默病小鼠模型中基因型和母体胆碱补充对脂联素的调节作用
J Clin Med. 2021 Jul 5;10(13):2994. doi: 10.3390/jcm10132994.
5
Opportunities, barriers, and recommendations in down syndrome research.唐氏综合征研究中的机遇、障碍与建议
Transl Sci Rare Dis. 2021;5(3-4):99-129. doi: 10.3233/trd-200090. Epub 2021 Apr 15.
6
Comparative efficacy of early morning versus bedtime administration of levothyroxine in children with hypothyroidism: a prospective, open label, randomized, case-control study.清晨与睡前给予左旋甲状腺素治疗甲状腺功能减退症儿童的疗效比较:一项前瞻性、开放标签、随机、病例对照研究。
Pediatr Endocrinol Diabetes Metab. 2021;27(3):178-182. doi: 10.5114/pedm.2021.105635.
7
Metabolic Diseases and Down Syndrome: How Are They Linked Together?代谢疾病与唐氏综合征:它们是如何联系在一起的?
Biomedicines. 2021 Feb 22;9(2):221. doi: 10.3390/biomedicines9020221.
8
Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.唐氏综合征是一种代谢性疾病:胰岛素信号改变介导外周和大脑功能障碍。
Front Neurosci. 2020 Jul 8;14:670. doi: 10.3389/fnins.2020.00670. eCollection 2020.
9
Down Syndrome, Obesity, Alzheimer's Disease, and Cancer: A Brief Review and Hypothesis.唐氏综合征、肥胖症、阿尔茨海默病与癌症:简要综述及假说
Brain Sci. 2018 Mar 24;8(4):53. doi: 10.3390/brainsci8040053.
10
Severe Early Onset Obesity due to a Novel Missense Mutation in Exon 3 of the Leptin Gene in an Infant from Northwest India.印度西北部一名婴儿因瘦素基因第3外显子的新型错义突变导致严重早发性肥胖。
J Clin Res Pediatr Endocrinol. 2018 Jul 31;10(3):274-278. doi: 10.4274/jcrpe.5501. Epub 2017 Dec 8.